These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 12195781

  • 1. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
    Lui SL, Tsang R, Wong D, Chan KW, Chan TM, Fung PC, Lai KN.
    Lupus; 2002; 11(7):411-8. PubMed ID: 12195781
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice.
    Yu CC, Yang CW, Wu MS, Ko YC, Huang CT, Hong JJ, Huang CC.
    J Lab Clin Med; 2001 Jul; 138(1):69-77. PubMed ID: 11433230
    [Abstract] [Full Text] [Related]

  • 3. Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice.
    Guo H, Leung JC, Chan LY, Lui SL, Tsang AW, Lai KN.
    Lupus; 2005 Jul; 14(8):583-92. PubMed ID: 16175929
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C, Benigni A, Noris M, Corna D, Casiraghi F, Pagnoncelli M, Rottoli D, Abbate M, Remuzzi G.
    Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
    [Abstract] [Full Text] [Related]

  • 5. L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis.
    Peters H, Border WA, Rückert M, Krämer S, Neumayer HH, Noble NA.
    Kidney Int; 2003 Apr; 63(4):1382-92. PubMed ID: 12631354
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of murine lupus nephritis by mycophenolate mofetil.
    Van Bruggen MC, Walgreen B, Rijke TP, Berden JH.
    J Am Soc Nephrol; 1998 Aug; 9(8):1407-15. PubMed ID: 9697662
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
    Jonsson CA, Svensson L, Carlsten H.
    Clin Exp Immunol; 1999 Jun; 116(3):534-41. PubMed ID: 10361247
    [Abstract] [Full Text] [Related]

  • 8. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM, Farrelly LW, Viti D, Redmond ST, Hutchison F, Ruiz P, Manning P, Connor J, Gilkeson GS.
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [Abstract] [Full Text] [Related]

  • 9. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis.
    Oates JC, Halushka PV, Hutchison FN, Ruiz P, Gilkeson GS.
    Am J Med Sci; 2011 Feb; 341(2):101-5. PubMed ID: 20924284
    [Abstract] [Full Text] [Related]

  • 10. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice.
    Yung S, Zhang Q, Chau MK, Chan TM.
    Autoimmunity; 2015 Feb; 48(7):471-87. PubMed ID: 26099989
    [Abstract] [Full Text] [Related]

  • 11. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
    Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS.
    J Exp Med; 1994 Feb 01; 179(2):651-60. PubMed ID: 7507509
    [Abstract] [Full Text] [Related]

  • 12. Effect of mycophenolate mofetil on nitric oxide production and inducible nitric oxide synthase gene expression during renal ischaemia-reperfusion injury.
    Lui SL, Chan LY, Zhang XH, Zhu W, Chan TM, Fung PC, Lai KN.
    Nephrol Dial Transplant; 2001 Aug 01; 16(8):1577-82. PubMed ID: 11477158
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.
    Cheng CC, Lee YF, Lan JL, Wu MJ, Hsieh TY, Lin NN, Wang JM, Chiu YT.
    Lupus; 2013 May 01; 22(6):554-61. PubMed ID: 23478030
    [Abstract] [Full Text] [Related]

  • 14. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice.
    Hortelano S, Díaz-Guerra MJ, Gonzalez-García A, Leonardo E, Gamallo C, Boscá L, Martínez-A C.
    J Immunol; 1997 Feb 01; 158(3):1402-8. PubMed ID: 9013985
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease.
    Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G.
    Kidney Int; 1997 May 01; 51(5):1583-9. PubMed ID: 9150476
    [Abstract] [Full Text] [Related]

  • 16. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.
    Fu J, Wang Z, Lee K, Wei C, Liu Z, Zhang M, Zhou M, Cai M, Zhang W, Chuang PY, Ma'ayan A, He JC, Liu Z.
    Kidney Int; 2018 Feb 01; 93(2):416-429. PubMed ID: 29102373
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 01; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.
    J Rheumatol; 2005 Jun 01; 32(6):1047-52. PubMed ID: 15940766
    [Abstract] [Full Text] [Related]

  • 19. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis.
    Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC.
    PLoS One; 2013 Jun 01; 8(5):e64650. PubMed ID: 23741359
    [Abstract] [Full Text] [Related]

  • 20. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis.
    Njoku CJ, Patrick KS, Ruiz P, Oates JC.
    J Investig Med; 2005 Nov 01; 53(7):347-52. PubMed ID: 16297360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.